329 related articles for article (PubMed ID: 18373560)
1. DJ-1-binding compounds prevent oxidative stress-induced cell death and movement defect in Parkinson's disease model rats.
Miyazaki S; Yanagida T; Nunome K; Ishikawa S; Inden M; Kitamura Y; Nakagawa S; Taira T; Hirota K; Niwa M; Iguchi-Ariga SM; Ariga H
J Neurochem; 2008 Jun; 105(6):2418-34. PubMed ID: 18373560
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effect of a new DJ-1-binding compound against neurodegeneration in Parkinson's disease and stroke model rats.
Kitamura Y; Watanabe S; Taguchi M; Takagi K; Kawata T; Takahashi-Niki K; Yasui H; Maita H; Iguchi-Ariga SM; Ariga H
Mol Neurodegener; 2011 Jul; 6(1):48. PubMed ID: 21740546
[TBL] [Abstract][Full Text] [Related]
3. Kaempferol derivatives prevent oxidative stress-induced cell death in a DJ-1-dependent manner.
Qu W; Fan L; Kim YC; Ishikawa S; Iguchi-Ariga SM; Pu XP; Ariga H
J Pharmacol Sci; 2009 Jun; 110(2):191-200. PubMed ID: 19498271
[TBL] [Abstract][Full Text] [Related]
4. Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.
Inden M; Kitamura Y; Takahashi K; Takata K; Ito N; Niwa R; Funayama R; Nishimura K; Taniguchi T; Honda T; Taira T; Ariga H
J Pharmacol Sci; 2011; 117(3):189-203. PubMed ID: 22041943
[TBL] [Abstract][Full Text] [Related]
5. PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model.
Inden M; Taira T; Kitamura Y; Yanagida T; Tsuchiya D; Takata K; Yanagisawa D; Nishimura K; Taniguchi T; Kiso Y; Yoshimoto K; Agatsuma T; Koide-Yoshida S; Iguchi-Ariga SM; Shimohama S; Ariga H
Neurobiol Dis; 2006 Oct; 24(1):144-58. PubMed ID: 16860563
[TBL] [Abstract][Full Text] [Related]
6. DJ-1-dependent protective activity of DJ-1-binding compound no. 23 against neuronal cell death in MPTP-treated mouse model of Parkinson's disease.
Takahashi-Niki K; Inafune A; Michitani N; Hatakeyama Y; Suzuki K; Sasaki M; Kitamura Y; Niki T; Iguchi-Ariga SM; Ariga H
J Pharmacol Sci; 2015 Mar; 127(3):305-10. PubMed ID: 25837927
[TBL] [Abstract][Full Text] [Related]
7. Identification of potential therapeutic compounds for Parkinson's disease using Drosophila and human cell models.
Sanz FJ; Solana-Manrique C; Muñoz-Soriano V; Calap-Quintana P; Moltó MD; Paricio N
Free Radic Biol Med; 2017 Jul; 108():683-691. PubMed ID: 28455141
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Activities of DJ-1 and Its Binding Compounds Against Neurodegenerative Diseases.
Inden M; Yanagisawa D; Hijioka M; Ariga H; Kitamura Y
Adv Exp Med Biol; 2017; 1037():187-202. PubMed ID: 29147910
[TBL] [Abstract][Full Text] [Related]
9. DJ-1-Mediated protective effect of protocatechuic aldehyde against oxidative stress in SH-SY5Y cells.
Gao JW; Yamane T; Maita H; Ishikawa S; Iguchi-Ariga SM; Pu XP; Ariga H
J Pharmacol Sci; 2011; 115(1):36-44. PubMed ID: 21160133
[TBL] [Abstract][Full Text] [Related]
10. DJ-1 binds to mitochondrial complex I and maintains its activity.
Hayashi T; Ishimori C; Takahashi-Niki K; Taira T; Kim YC; Maita H; Maita C; Ariga H; Iguchi-Ariga SM
Biochem Biophys Res Commun; 2009 Dec; 390(3):667-72. PubMed ID: 19822128
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective function of DJ-1 in Parkinson's disease.
Ariga H; Takahashi-Niki K; Kato I; Maita H; Niki T; Iguchi-Ariga SM
Oxid Med Cell Longev; 2013; 2013():683920. PubMed ID: 23766857
[TBL] [Abstract][Full Text] [Related]
12. DJ-1-binding compound B enhances Nrf2 activity through the PI3-kinase-Akt pathway by DJ-1-dependent inactivation of PTEN.
Niki T; Endo J; Takahashi-Niki K; Yasuda T; Okamoto A; Saito Y; Ariga H; Iguchi-Ariga SMM
Brain Res; 2020 Feb; 1729():146641. PubMed ID: 31891690
[TBL] [Abstract][Full Text] [Related]
13. Transduced Tat-DJ-1 protein protects against oxidative stress-induced SH-SY5Y cell death and Parkinson disease in a mouse model.
Jeong HJ; Kim DW; Woo SJ; Kim HR; Kim SM; Jo HS; Park M; Kim DS; Kwon OS; Hwang IK; Han KH; Park J; Eum WS; Choi SY
Mol Cells; 2012 May; 33(5):471-8. PubMed ID: 22526393
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of DJ-1 neuroprotection in a cellular model of Parkinson's disease.
Liu F; Nguyen JL; Hulleman JD; Li L; Rochet JC
J Neurochem; 2008 Jun; 105(6):2435-53. PubMed ID: 18331584
[TBL] [Abstract][Full Text] [Related]
15. Distribution of DJ-1, Parkinson's disease-related protein PARK7, and its alteration in 6-hydroxydopamine-treated hemiparkinsonian rat brain.
Yanagida T; Takata K; Inden M; Kitamura Y; Taniguchi T; Yoshimoto K; Taira T; Ariga H
J Pharmacol Sci; 2006 Oct; 102(2):243-7. PubMed ID: 17038803
[TBL] [Abstract][Full Text] [Related]
16. Establishment of specific antibodies that recognize C106-oxidized DJ-1.
Ooe H; Iguchi-Ariga SM; Ariga H
Neurosci Lett; 2006 Aug; 404(1-2):166-9. PubMed ID: 16781058
[TBL] [Abstract][Full Text] [Related]
17. [Function of DJ-1 in mitochondria].
Takahashi-Niki K; Niki T; Iguchi-Ariga S; Ariga H
Yakugaku Zasshi; 2012; 132(10):1105-10. PubMed ID: 23037695
[TBL] [Abstract][Full Text] [Related]
18. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
Büeler H
Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
[TBL] [Abstract][Full Text] [Related]
19. Reduced anti-oxidative stress activities of DJ-1 mutants found in Parkinson's disease patients.
Takahashi-Niki K; Niki T; Taira T; Iguchi-Ariga SM; Ariga H
Biochem Biophys Res Commun; 2004 Jul; 320(2):389-97. PubMed ID: 15219840
[TBL] [Abstract][Full Text] [Related]
20. DJ-1/PARK7: A New Therapeutic Target for Neurodegenerative Disorders.
Hijioka M; Inden M; Yanagisawa D; Kitamura Y
Biol Pharm Bull; 2017; 40(5):548-552. PubMed ID: 28458339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
